Six months after announcing a first wave of cost cuts, Novavax is instituting another round, looking to shave off a further $300 million in spending with more layoffs on the way.
https://www.fiercebiotech.com/biotech/novavax-plans-second-round-cost-cuts-weak-vaccine-uptake-pummels-manufacturers